• Skip to content

Biotech Animated

Biotech Animated | Biotechnology & Life-Science Animation | Beautifully Deliver Your Life-science Company’s Message to a Greater Audience | Biotech Animated is a Life-Science Animation, Advertising Strategy and Business Development Firm

Main navigation

  • Projects
  • About
  • What We Do
  • Our Story
  • Team
  • Join Us
  • Contact Us

Harnessing receptor heteromerization for drug discovery and development

*Please scroll down to the bottom of the page for the final deliverable.

Project Overview

Dimerix is a clinical stage biotechnology company focused on developing new therapeutics discovered using their proprietary drug development Receptor-Heteromer Investigation Technology platform. Dimerix’s lead therapy DMX-200 is currently in Phase II clinical trials for chronic kidney disease and has received US Orphan Drug Designation for Focal Segmental Glomerulosclerosis.

The primary objective of this project is to attract the interest of investors. The secondary objective is to create new business partnerships. Video 2 explains the Receptor-Heteromer Investigation Technology.

The target audience for video 2 are scientifically trained and have a reasonably good understanding of the drug discovery process.

Storyboard

dimerix-2-mp4_000005243

At Dimerix, we’ve developed our cell-based Receptor-HIT assay to identify and interrogate GPCR heteromers.

dimerix-2-mp4_000013608

This flexible platform works with a wide range of molecular targets, reducing the risk of unidentified signaling interactions.

dimerix-2-mp4_000024360

Our patented BRET assay can be configured as a three-component system comprised of an unlabeled GPCR,

dimerix-2-mp4_000027144

a second GPCR fused to luciferase,

dimerix-2-mp4_000029984

and a signaling molecule fused to a fluorophore.

dimerix-2-mp4_000031271

When a ligand binds to the unlabeled GPCR and heteromerizes with the labeled GPCR,

dimerix-2-mp4_000041233

the fluorophore is brought close enough to the luciferase to generate a signal.

dimerix-2-mp4_000048201

Because this assay is highly dependent on proximity, no signal is generated in the absence of a ligand

dimerix-2-mp4_000051642

or when the GPCRs form homodimers, resulting in a robust assay with low background.

dimerix-2-mp4_000060456

Due to its unique ability interrogate the pharmacodynamics of GPCR complexes,

dimerix-2-mp4_000069214

our Receptor-HIT assay is great for repurposing approved compounds, de-orphanizing receptors, and conducting de novo drug discovery.

dimerix-2-mp4_000079233

To see how you can partner with Dimerix and take advantage of this powerful technology, email info@dimerix.com.

Final Video Deliverable

 

This video is currently live here

  • Join Us
  • Contact Us

COPYRIGHT © 2023 BIOTECH ANIMATED